AstraZeneca, PTC in cancer discovery deal

AstraZeneca plc (LSE:AZN; NYSE:AZN) partnered with PTC Therapeutics Inc. (South Plainfield, N.J.) to discover and develop therapeutics using PTC's Gene Expression Modulation by Small-molecules (GEMS) ...